India Pharmas Can Expect Up To 14% Growth This Fiscal Year, Execs Say
This article was originally published in PharmAsia News
Executive Summary
India's pharmaceutical industry is forecast to see revenue growth of as much as 14% in the just-begun current fiscal year, reversing a negative impact of recent trade issues and government price controls.